ReviewInternational journal of molecular sciences2021

Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era.

Guido Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.